new_adrs_0322_0123|ACHL|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_adrs_0322_0123|ACHL|1|Achilles Therapeutics PLC Total Current Assets (Quarterly) (USD)|Achilles Therapeutics PLC Cash and Short Term Investments (Quarterly) (USD)|Achilles Therapeutics PLC Inventories (Quarterly) (USD)|Achilles Therapeutics PLC Net PP&E (Quarterly) (USD)|Achilles Therapeutics PLC Goodwill and Intangibles (Quarterly) (USD)|Achilles Therapeutics PLC Total Liabilities (Quarterly) (USD)|Achilles Therapeutics PLC Total Current Liabilities (Quarterly) (USD)|Achilles Therapeutics PLC Total Long Term Liabilities (Quarterly) (USD)|Achilles Therapeutics PLC Total Deposits (Quarterly) (USD)|Achilles Therapeutics PLC Book Value (Quarterly) (USD)|Achilles Therapeutics PLC Retained Earnings (Quarterly) (USD)|Achilles Therapeutics PLC Treasury Stock (Quarterly) (USD)|Achilles Therapeutics PLC EV to Revenues|Achilles Therapeutics PLC EV to Earnings|Achilles Therapeutics PLC EV to Free Cash Flow|Achilles Therapeutics PLC EV to Assets (Quarterly)|Achilles Therapeutics PLC PS Ratio|Achilles Therapeutics PLC PE Ratio|Achilles Therapeutics PLC Price to Book Value|Achilles Therapeutics PLC PEG Ratio|Achilles Therapeutics PLC Debt to Equity Ratio|Achilles Therapeutics PLC Dividend Yield|Achilles Therapeutics PLC Shareholder Yield (TTM)|Achilles Therapeutics PLC Percent of Shares Outstanding Short|Achilles Therapeutics PLC Total Receivables (Quarterly) (USD)|Achilles Therapeutics PLC Total Payables (Quarterly) (USD)|Achilles Therapeutics PLC Total Capital Stock (Quarterly) (USD)|Achilles Therapeutics PLC Return on Invested Capital|Achilles Therapeutics PLC Quality Ratio Score|Achilles Therapeutics PLC Momentum Score|Achilles Therapeutics PLC Beta (1Y)|Achilles Therapeutics PLC Sustainable Growth Rate (TTM)|Achilles Therapeutics PLC Institutional Investor Ownership Percentage|Achilles Therapeutics PLC Average Diluted Shares Outstanding (Quarterly)|Achilles Therapeutics PLC Total Employees (Annual)|Achilles Therapeutics PLC EPS Diluted (Quarterly) (USD)|Achilles Therapeutics PLC Shares Outstanding|Achilles Therapeutics PLC Repurchase of Capital Stock (Quarterly) (USD)|Achilles Therapeutics PLC Ordinary Shares Number (Quarterly)|Achilles Therapeutics PLC Payout Ratio|Achilles Therapeutics PLC Quick Ratio (Quarterly)|Achilles Therapeutics PLC Normalized Diluted EPS (Quarterly) (USD)|Achilles Therapeutics PLC Stock Buybacks (Quarterly) (USD)|Achilles Therapeutics PLC Effective Tax Rate (TTM)|Achilles Therapeutics PLC Return on Equity|Achilles Therapeutics PLC Net Income (TTM) (USD)|Achilles Therapeutics PLC Revenue (TTM) (USD)|Achilles Therapeutics PLC Dividend Per Share (Quarterly) (USD)|Achilles Therapeutics PLC Revenue (Quarterly) (USD)|Achilles Therapeutics PLC Gross Profit (Quarterly) (USD)|Achilles Therapeutics PLC SG&A Expense (Quarterly) (USD)|Achilles Therapeutics PLC Pre-Tax Income (Quarterly) (USD)|Achilles Therapeutics PLC Net Income (Quarterly) (USD)|Achilles Therapeutics PLC Net Interest Income (Quarterly) (USD)|Achilles Therapeutics PLC Price (USD)|Achilles Therapeutics PLC Total Return Price (USD)|Achilles Therapeutics PLC Enterprise Value (USD)|Achilles Therapeutics PLC 30-Day Average Daily Volume|Achilles Therapeutics PLC 1 Year Price Returns (Daily)||
new_adrs_0322_0123|ACHL|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_adrs_0322_0123|ACHL|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly||
new_adrs_0322_0123|ACHL|5|91.25|91.25||91.25||91.25|91.25|91.25||91.25|91.25||||1.44444444444||||1.44262295082|||1.44262295082||15.1818181818|91.25|91.25|91.25||||||30.3636363636|91.4285714286|365|91.4285714286|62.6||91.25|||91.4285714286|91.25|91.25||91.25|||||91.4285714286|91.4285714286|91.4285714286||1.44262295082|1.44262295082|1.44262295082|1.44186046512|||
new_adrs_0322_0123|ACHL|6|4|4||4||4|4|4||4|4||||117||||244|||244||22|4|4|4||||||11|7|1|7|5||4|||7|4|4||4|||||7|7|7||244|244|244|215|||
new_adrs_0322_0123|ACHL|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_adrs_0322_0123|ACHL|202003||||||||||||||||||||||||||||||||||1.6419||-3.1755||||||-3.1755|||||||||1.736|-5.214|-5.214||||||||
new_adrs_0322_0123|ACHL|202006||||||||||||||||||||||||||||||||||1.6419||-4.1749||||||-4.1749|||||||||2.395|-6.855|-6.855||||||||
new_adrs_0322_0123|ACHL|202009||||||||||||||||||||||||||||||||||1.6419||-5.0002||||||-5.0002|||||||||3.009|-8.21|-8.21||||||||
new_adrs_0322_0123|ACHL|202012|187.797|177.849||28.109||29.546|16.623|12.923||189.238|-58.012||||||||||||||7.339|6.321|0.14|||||||40.6218|159|-0.3181|||40.6218|||-0.3181||-0.009||-33.199|||||3.958|-12.917|-12.92||||||||
new_adrs_0322_0123|ACHL|202103|173.32|159.262||29.634||27.05|15.062|11.988||178.919|-71.777||||||||3.7575|||||0.6479|9.056|1.806|0.14||||||56.5965|1.6419||-8.38|40.6218||40.6218|||-8.38||-0.0359||-41.75|||||4.832|-13.753|-13.765||16.55|16.55|513.1628|34519.3333||15.55|12.63
new_adrs_0322_0123|ACHL|202106|320.402|299.317||29.847||29.516|18.613|10.903||323.974|-87.933||||||||1.227|||||0.7161|11.963|6.074|0.054||||||81.2314|35.6832||-0.45|40.6035||40.6035|||-0.45||-0.0549||-51.051|||||5.445|-16.143|-16.156||9.79|9.79|98.1913|16665.8333||5.83|6.78
new_adrs_0322_0123|ACHL|202109|298.276|281.875||28.316||24.89|15.366|9.524||304.981|-100.881||||-0.3449||||1.0371|||||1.8862|8.293|2.496|0.182||||||67.3262|38.2615||-0.34|40.6035||40.6035|||-0.34|-160.755|-0.0789||-55.789|||||5.041|-12.932|-12.948||7.79|7.79|34.5543|183875.9667||6.14|5.1
new_adrs_0322_0123|ACHL|202112|284.749|266.319||28.791||27.578|19.11|8.468||289.4|-119.111||||0.6266||||0.7029|||||0.1907|11.173|3.722|0.182||||||61.8229|38.63|252|-0.44|40.6035||40.6035|||-0.44||-0.0606||-61.099|||||6.653|-18.234|-18.23||5.01|5.01|-62.7675|132791.1333||3.8|3.31
new_adrs_0322_0123|ACHL|202203|||||||||||||||1.3652||||0.4473||||||||||||||||||||||||||||||||||||3.32|3.32|-136.7538|37110.6333|||